The global drug discovery informatics market was valued approximately
US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0%
from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025,
according to a new market report published by Transparency Market
Research (TMR) titled “Drug Discovery Informatics Market - Global
Industry Analysis, Size, Share, Growth, Trends, and Forecast,
2017–2025”. The report suggests that the cost and time of drug
discovery are reduced to a very large extent in comparison with the
traditional drug discovery process are spur the demand of drug
discovery informatics in the coming years (2017 to 2025). As key
players introduce their drug discovery using informatics in developed
markets such a North America and Western Europe, these regions are
likely to account for dominating share of the global drug discovery
informatics market. The increasing number of uses of the drug
discovery informatics such as the scientists use it to communicate
their ideas with their colleagues in computational chemistry, and
biology to design small parallel libraries, and to conduct their own
preliminary analysis of interactions between the ligand and receptor
in emerging markets such as China and India is likely to boost growth
of Asia Pacific drug discovery informatics market at a CAGR of around
20.0% from 2017 to 2025.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33713
The rising laboratory informatics such as sharing, and searching of
digital discovery information, and electronic lab notebook for the
improved storage are driving the growth of the drug discovery
informatics. The technological advancements in the drug discovery
informatics that are employed by computational informatics are
leading to developments in scientific innovation. The cost and time
of drug discovery are reduced to a very large extent that drive the
growth of the global drug discovery informatics market. However,
there are only a few institutions and organizations in the world to
train on drugs discovery informatics; moreover, the related
experience is low in trained professionals, which in turn has
attributed for devaluation of the market, there by restraining growth
of global drug discovery informatics market.
The Global Drug Discovery Informatics Market is classified on the
basis of product, mode, function, end-user, and region. Based on the
product, the market is divided into development informatics, and
discovery informatics. The discovery informatics segment dominated
the market in terms of revenue in 2016, due to its cost benefits.
Development informatics is anticipated to grow during the forecast
period owing to the technological advancements in the development
informatics. In terms of mode the market can be categorized into
outsourced informatics, and in-house informatics. Outsourced
informatics is estimated to dominate in terms of revenue in 2016
owing to the rise in collaborations and lead drug discovery projects
between pharmaceutical companies, and IT market participants.
In-house informatics is anticipated to grow in the coming years due
to rise in the awareness regarding the time and cost benefits in the
long run for the biotechnological and pharmaceutical companies.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=33713
Based on function the market can be classified into sequencing and
target data analysis, docking, lead generation informatics,
identification & validation informatics, molecular modeling, and
others. Sequencing and target data analysis is estimated to dominate
the market in 2016, owing to reduced cost of sequencing informatics.
Molecular modeling segment is anticipated to grow during the forecast
period owing to the increasing number of applications of small
molecules in drug discovery. In terms of end-user the market can be
divided into contract research organizations, pharmaceutical &
biotechnology companies, and others. Contract research organizations
(CROs) segment is estimated to dominate in 2016, owing to increasing
number of CROs all over the world for drug discovery. Pharmaceutical
and biotechnological companies segment is anticipated to grow during
the forecast period owing to the long term time and cost benefits of
the drug discovery informatics.
Geographically, the global drug discovery informatics market can be
categorized into Latin America, Middle East & Africa, Asia
Pacific, Europe, and North America. North America held the large
market share in 2016, and is anticipated to dominate during the
forecast period. The increasing technological advancements in the
drug discovery informatics in the region is likely to augment the
market of Drug Discovery Informatics in North America. Europe
accounted for the second large market share in global drug discovery
informatics market defibrillators in terms of revenue in 2016. Rising
prevalence of the infectious diseases and cancerous diseases drive
the growth in the region. Asia pacific is anticipated to grow at the
fastest growth rate during the forecast period. This is attributed to
high adoption of drug discovery informatics that has led to major
share held by Asia Pacific in the global drug discovery informatics
market. Moreover, a large pool of patients with infectious diseases
and favorable government initiatives for the health care sector in
countries such as Japan, Singapore, and Dubai are likely to present
immense opportunities for growth of the market in the region in the
next few years. Middle East & Africa and Latin America are
expected to grow during the forecast period. Rising awareness
regarding the drug discovery informatics in the regions is
anticipated to grow the demand for the drug discovery informatics
during the forecast period.
The report also provide profiles of leading players operating in
global drug discovery informatics market include Charles River
Laboratories International, Inc., Thermo Fisher Scientific,
PerkinElmer Inc., Biogen Inc., Boehringer Ingelheim GmbH, Insilico
Medicine, Inc., International Business Machines Corporation,
Schrödinger, LLC, Albany Molecular Research Inc. (AMRI), and
Certara, L.P. These players are adopting the growth strategies that
increase their product offerings, strengthen their geographical
reach, increase customer base and garner market share. For instance,
Thermo Fisher Scientific, one of the global company that offers a
wide range of bio-analytical, diagnostics, and laboratories products
has in-house drug discovery informatics. Such in-house drug discovery
informatics are anticipated to expand in the during the forecast
period.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment